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Background: Surgery has wide ranging immunomodulatory properties of which the mechanism is poorly
understood. In order to investigate how different types of surgery influence inflammation, we designed a
longitudinal observational study investigating two inflammatory profiles of two separate patient groups undergoing
gynaecological operations of differing severity. In addition to measuring the well known inflammatory markers
neopterin and IL-6, we also determined the kynurenine/tryptophan ratio.
This study was a prospective, single center, two-armed observational study involving 28 female patients. Plasma
levels of tryptophan, kynurenine, neopterin and IL-6 were determined from samples taken at: 24hrs pre-operative,
prior to induction, ten minutes before the operation was expected to end, and at 24 and 96 hours post operative
in patients undergoing abdominal hysterectomy and vulvectomy.
Results: There were 15 and 13 patients included in the vulvectomy and abdominal hysterectomy groups,
respectively. In this study we show that anesthesia and surgery significantly increases the enzyme activity of
indoleamine 2, 3 dioxygenase (IDO) as measured by the kynurenine/tryptophan ratio (P=0.003), while maintaining
stable neopterin levels. However, abdominal hysterectomy causes a considerable IL-6 increase (P<0.001).
Conclusion: Surgery and associated anesthesia cause a significant tryptophan level decrease while significantly
increasing IDO activity. Both types of surgery produce nearly identical neopterin time curve relationships, with no
significant change occurring in either group. However, even though neopterin is unaffected by the severity of
surgery, IL-6 responded to surgical invasiveness by revealing a significant increase during abdominal hysterectomy.
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Surgery has wide ranging immunomodulatory properties
of which the mechanism is poorly understood [1-3]. In
order to better understand the effect of surgery and
anesthesia on inflammation, we designed a longitudinal
observational study investigating two inflammatory pro-
files of two separate patient groups undergoing surgery
of differing severity while undergoing general anesthesia.
In addition to measuring the well known inflammatory
markers neopterin and IL-6, we also determined kynure-
nine and tryptophan.* Correspondence: j.w.hol@erasmusmc.nl
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unless otherwise stated.Tryptophan is an essential precursor for serotonin and
kynurenine (KYN) [4]. The metabolism of tryptophan to
kynurenine is facilitated by the enzyme Indoleamine 2,3
dioxygenase (IDO) [5]. Tryptophan is a vital amino acid for
growth. When present in limited amounts it inhibits viral,
bacterial and parasitic development. Not only are microor-
ganisms dependent on tryptophan, but T-cell production is
also limited by decreased levels [6-8]. Kynurenine, the dir-
ect product of tryptophan catabolism has several important
physiological and immunosuppressive properties. It regu-
lates immune function by suppressing T-cells and natural
killer cells [9,10]. Moreover, recent research has found that
it contributes to arterial vessel wall relaxation and causes
hypotension in a dose dependent manner in systemically
inflamed mice [11].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the rate limiting enzyme IDO [5,12] (Figure 1). IDO is
made in the vascular endothelial cells and is activated
via autocrine and paracrine mechanisms by means of
interferon γ (IFN γ) released by dendritic and T-cells
[13,14]. The amount of kynurenine produced relates to
its activity [12,15]. In addition, IDO contributes to the
regulation of blood pressure because it controls the pro-
duction of kynurenine. This has been demonstrated by
the ability of IDO inhibitors to restore normal systolic
blood pressure in septic mice [11].
Tryptophan degradation is correlated to neopterin for-
mation; both are stimulated by IFN γ [4,16-19]. Increased
neopterin levels are associated with a pro-inflammatory
state mediated by cellular immune system activation
[20-22]. It is an endogenous regulator of cytotoxic effects
by activated macrophages and a potent enhancer of perox-
ynitrite [23]. It is a stable molecule eliminated only by the
kidney. Higher levels are associated with higher levels of
reactive oxygen species and thus serve as an estimate of
the oxidative stress caused by the immune system [24,25].
Levels of neopterin have been shown to predict the de-
velopment of septic complications in trauma and post
surgical patients. There is a direct correlation between in-
creased neopterin levels and non-survivors [26].
IL-6 is an acute phase pro-inflammatory cytokine cap-
able of being released by macrophages, endothelial cells
and T-cells minutes after injury. It is a good marker for
acute immune system activation and is accepted as a
sensitive early marker of tissue damage with peak serum
levels being proportional to the amount of surgical
trauma [27-30]. Known to be made within minutes afterFigure 1 An overview of the tryptophan kynurenine pathway and its
activates and or stimulates production.injury, it is also broken down in a relatively short
amount of time [31,32].
Quantifying the above mentioned biochemical substances
in blood may give us more insight into peri-operative im-
munomodulatory processes. Significantly different inflam-
matory profiles can have wide clinical implications. We
hypothesize that more invasive surgery when compared to
minor surgery causes significantly more increases in all in-
flammatory biomarkers measured.
Methods
Study set-up and inclusion criteria
This study was a prospective, single centre, two-armed ob-
servational study with 28 female patients. The protocol was
approved by the Medical Ethics Committee of the Erasmus
Medical Centre, Rotterdam (MEC-2008-134). All proce-
dures were performed in accordance with the Helsinki dec-
laration. Informed consent was obtained from all patients.
Inclusion criteria were 1) scheduled for vulvectomy or
abdominal hysterectomy, 2) expected surgery duration
greater than 0.5 h, 3) postoperative hospitalization lasting
more than 4 days, 4) age greater than 18 years, 5) ASA
(American Society of Anesthesiologists) classification I-III.
Exclusion criteria were 1) ASA-classification IV-V, 2) pa-
tients unable to speak Dutch, 3) and patients not able to
consent. Patients had the right to withdraw from the study
at any time. Patients who developed serious adverse side
effects were to be withdrawn from the study.
Anesthesia procedure
All patients received 1.0 mg tablet lorazepam and 100 mg
celecoxib (selective COX-2 inhibitor) approximately onerelationship with IFN γ as well as neopterin. (+) denotes that it
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ued during the study. The observational nature of this
study allowed the staff anesthesiologist to place an epi-
dural catheter if the anesthesiologist felt it was indicated
for adequate post operative pain control. All patients re-
ceived total intravenous anesthesia, using propofol for sed-
ation and sufentanil for analgesia. Cisatracurium provided
muscle relaxation for patients being intubated. Prior to
the first incision all patients received antibiotics (1 g cefa-
zoline and 500 mg metronidazol).
For all patients the minimum post operative pain control
regimen included 4000 mg paracetamol and 200 mg cele-
coxib per 24 hours. While in the recovery room, morphine
was titrated until sufficient pain control was achieved. The
daily regimen of paracetamol and celecoxib was continued
until patients no longer experienced pain with a VAS
greater than four. Patients with an epidural catheter had it
removed when the anesthesiologist determined that it was
no longer indicated for adequate pain control.
Outcome measures
Patient demographics, medications used during and after
surgery, and duration of surgery were documented.
EDTA blood samples (4 ml) were collected for determin-
ation of neopterin, kynurenine, and tryptophan at
24 hours pre-operative, right after IV placement prior to
induction, ten minutes before anesthesia was expected
to end, and at 24 and 96 hours post operative. Plasma
was isolated by centrifugation at 2650 gmax for 20 mi-
nutes at 20°C; samples were stored at -80°C until assay.
At the same time points blood was collected for prepar-
ation of serum used for the measurement of IL-6.
Concentrations of kynurenine and tryptophan were de-
termined via their natural fluorescence using an isocratic,
reversed-phase HPLC system (Agilent) and an FP-2020
fluorescence detector (Jasco) as described previously [33].
The analytical column consisted of a 250 × 2.1 mm i.d.
column packed with 5 μm particles of GraceSmart RP-18
(Grace Davison Discovery Sciences), which was protected
by a guard cartridge column (4.0 × 2.0 mm i.d.) containing
Phenomenex C18 material. An HP ChemStation (Hewlett
Packard) was used for data collection and handling. The
kynurenine/tryptophan ratio was calculated to estimate
the activity of the enzyme indoleamine 2,3 dioxygenase
(IDO) [34].
Total neopterin was measured after acid oxidation.
Plasma (0.4 ml) was oxidized in 0.1 ml 1 M trichloroacetic
acid and 0.05 ml iodine solution (0.5% I2, 1% KI in 0.2 M
trichloroacetic acid). After standing for 60 min under re-
duced light, excess iodine was reduced by the addition of
20 μl of 1% ascorbic acid solution and the mixture was
centrifuged at 12 000 × g for 15 min at 4°C. The super-
natant (0.4 ml) was transferred to an amber glass vial and
10 μl was injected directly onto the analytical columnusing an HPLC system with an auto sampler and a fluor-
escence detector as described previously [35].
Enzyme immunoassays for the quantitative determination
of human IL-6 were performed with a sandwich ELISA
(Pelikine Compact™ and additional Pelikine Toolset™,
Sanquin, Amsterdam, The Netherlands) as described previ-
ously [36]. Data were calculated as pg/ml. IL-6 Figures were
made with Sigma Plot, version 9.0. The results are pre-
sented as mean ± the standard error of the mean (SEM).
Statistical analysis
Data was analyzed using SPSS for windows, version 16.01.
The independent sample t-test was used to compare
means for patient demographics (excluding ASA classi-
fication) and peri-operative characteristics. The Pearson
Chi-square test was used to evaluate differences in
ASA classification. The Fisher exact test was used to
analyze difference in the type of pain control tech-
niques used between groups (NSAID only, NSAID +
Opiates, NSAID + Opiates + Epidural). All data are re-
ported as the mean ± SD.
Our biochemical data were analyzed using MANOVA.
Differences in values measured between the experimental
groups across all time points and interaction between ex-
perimental groups and time were analyzed using multi-
variate repeated measures. Experimental group and time
were the independent variables. When Mauchly’s Test of
Sphericity was significant, the Greenhouse-Geisser test
was used.
When a significant difference was found between ex-
perimental groups a one-way ANOVA test with post-
hoc multiple comparisons (Bonferroni correction) was
used to analyze the relationship between the level of the
amino acid from the first pre-operative measurement
until 96 hours post operative. The same Bonferroni cor-
rection was employed to analyze differences between ex-
perimental groups and time. Pairwise comparisons were
used to analyze significant differences between longitu-
dinal time points. P-value <0.05 was considered statisti-
cally significant.
Results
Demographics
Twenty eight female patients were included in the study;
no patients were withdrawn from the study (Table 1).
The vulvectomy group contained 15 patients, while the
laparotomy group contained 13 patients. Significant in-
tergroup differences were found for age and ASA classi-
fication (P < 0.05). Laparotomy patients were younger
and had significantly lower ASA scores.
Perioperative characteristics
Differences in perioperative characteristics were found
(Table 2). The abdominal hysterectomy group had a
Table 1 Patient demographics
Vulvectomy Laparotomy
Age (years) 62 ± 12 44 ± 9*
Height (cm) 166 ± 5 167 ± 6
Weight (kg) 71 ± 10 71 ± 7
Data are mean ± SD.
*Significant difference between groups, P < 0.001.
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loss (P < 0.001) and correspondingly more fluid replace-
ment in the form of colloids (P = 0.002) and crystalloids
(P = 0.005). In addition, significantly more propofol was
used (P = 0.026), however, there was no significant differ-
ence in the amount of sufentanil used between groups.
One of the patients in the laparotomy group received a
blood transfusion with 285 ml of erythrocytes.
There was no significant difference in the amount of
post operative morphine, paracetamol or celecoxib given
to both groups (Table 3). However, 9 patients from the
laparotomy group were given pre-operative epidural
catheters while only 3 patients were given one in the
vulvectomy group. All epidural catheters were removed
by 24 hours post–operative because pain control was
found to be adequate.
Plasma tryptophan levels
Baseline levels of plasma tryptophan 24 hours before sur-
gery did not significantly differ between groups. Through-
out time, no significant difference between experimental
groups was found. There was however a significant within
subject effect over time (P < 0.001) (Figure 2).
Pairwise comparisons reveal a significant decrease be-
tween plasma tryptophan measured prior to induction
and thirty minutes prior to the end of the operation (P <
0.001). Following this significant decrease there was a
significant increase between plasma tryptophan mea-
sured thirty minutes prior to the end of the operation
and plasma measured 24 hours post operative (P <
0.001).Table 2 Perioperative characteristics
Vulvectomy Laparotomy
Propofol during operation (mg) 1146 ± 828 1983 ± 105*
Operation time (min) 126 ± 50 188 ± 46*
Blood loss during operation (ml) 134 ± 271 959 ± 335ª
Colloids during operation (ml) 170 ± 242 540 ± 335*
Crystalloids during operation (ml) 1182 ± 627 1917 ± 655*
Sufentanil during operation (μg) 33 ± 15 37 ± 14
Cisatracurium during operation (mg) 20 ± 25 68 ± 18*
Data are mean ± SD.
*Significant difference between groups, P < 0.05.
ªSignificant difference between groups, P < 0.001.Plasma IDO activity, defined by the ratio of tryptophan/
kynurenine
Baseline levels of plasma IDO activity were not signifi-
cantly different between both groups. There was a sig-
nificant within subject effect over time (P < 0.001). In
addition, a significant difference between experimental
groups was found (P = 0.041) (Figure 3).
Pairwise comparisons reveal a significant increase in
plasma IDO activity measured prior to induction and
thirty minutes prior to the end of the operation (P =
0.003). Following this significant increase there was a sig-
nificant decrease between plasma IDO activity measured
thirty minutes prior to the end of the operation and
plasma measured 24 hours post operative (P < 0.001).
Plasma kynurenine
Baseline levels of plasma kynurenine were not significantly
different between both groups. There was a significant
change in plasma kynurenine levels over time for both
groups (P < 0.001) as well as a significant difference be-
tween experimental groups (P = 0.032). At 96 hours post
operative, the vulvectomy group had significantly higher
levels of plasma kynurenine than the laparotomy group
(P = 0.028) (Figure 3).
Pairwise comparisons reveal a significant decrease in
plasma kynurenine measured prior to induction and
thirty minutes prior to the end of the operation (P <
0.001). Following this significant decrease there was a
significant increase between thirty minutes prior to the
end of the operation and plasma measured 24 hours
post operative (P < 0.041).
Plasma neopterin levels
Baseline levels of plasma neopterin significantly differed
between both groups (P = 0.002); the vulvectomy group
having much higher levels than the laparotomy group. A
significant plasma neopterin level change occurred over
time for both groups (P < 0.033). There was also a signifi-
cant difference between experimental groups (P = 0.005)
(Figure 4).
Plasma IL-6 levels
Baseline levels of plasma IL-6 were not significantly dif-
ferent. A significant plasma IL-6 level change over time
occurred for both groups (P < 0.001). There was no sig-
nificant difference between groups. However, the major
abdominal surgery group had produced significantly
more IL-6 than the vulvectomy group 30 minutes prior
to the end of the operation (P < 0.001) (Figure 5).
Discussion
In this study we show that surgery and associated
anesthesia significantly increase IDO activity, while
maintaining stable neopterin levels. However, abdominal
Table 3 Postoperative characteristics
Vulvectomy Laparotomy
24 hours post-operative 96 hours post-operative 24 hours post-operative 96 hours post-operative
Paracetamol (mg) 3769 ± 832 4000 ± 0 3833 ± 577 4000 ± 0
Celecoxib (mg) 200 ± 0 186 ± 38 200 ± 0 233 ± 82
Morphine (mg) 6 ± 2 - 12 ± 1 -
Data are mean ± SD. Celecoxib (selective COX-2 inhibitor).
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gitudinal observational study, we believe we are the first
to compare how two well defined surgical interventions
of differing severity affect the tryptophan kynurenine
pathway and the two inflammatory mediators neopterin
and IL-6. It must be stressed, that there are differences
in age and ASA-score between the groups. It was not
our intention to compare two more or less identical
groups. Due to the fact that the higher age and the
higher ASA-score are associated with the vulvectomy
group while most changes occur in the younger and
healthier abdominal hysterectomy group, we can con-
clude that the observed effects are caused by the proced-
ure and not by comorbidity.Figure 2 The effect of anesthesia in patients undergoing vulvectomy
tryptophan. Values are the mean and SEM. There was a significant within
induction and 30 minutes prior to the end of operation ( bracket P < 0.001
operation and 24 hours post operative (bracket P < 0.001).Our tryptophan results show that in both groups
stable baseline levels significantly decrease after induc-
tion with a significant rebound occurring during the
24 hour period after surgery. This data suggest that tryp-
tophan is being rapidly consumed after induction.
Anesthesia has been shown to cause IFN gamma release
which in turn activates the enzyme IDO [37-39]. Our re-
sults show that there is significant activation (P = 0.003)
of the IDO enzyme as suggested by the tryptophan/
kynurenine ratio measured in both groups. During the
24 hours following surgery, however, a significant deacti-
vation of IDO occurs (P < 0.001), although 96 hours after
surgery IDO activity returns to pre-operative levels. The
significant kynurenine increase seen between the end ofand major abdominal surgery on perioperative levels of plasma
subject effect (P < 0.001). There was a significant decrease prior to
). A significant increase occurred 30 minutes prior to the end of
Figure 3 Line graph. The effect of anesthesia in patients undergoing vulvectomy and major abdominal surgery on perioperative IDO activity as
defined by the ratio of tryptophan/kynurenine. Values are the mean and SEM. There was a significant within subject effect (P < 0.001). In addition,
a significant difference between experimental groups was found (P = 0.041). There was a significant increase in plasma IDO activity measured
prior to induction and thirty minutes prior to the end of the operation (bracket P = 0.003). A significant decrease occurred between IDO activity
measured prior to the end of the operation and levels measured at 24 hours post operative (bracket P < 0.001). Bar graph: The effect of
anesthesia in patients undergoing vulvectomy and major abdominal surgery on perioperative levels of KYN. Values are the mean and SEM. There
was a significant within subject effect (P < 0.001) as well as a significant difference between experimental groups (P = 0.032). At 96 hours post
operative, the laparotomy group had significantly lower levels of plasma KYN than the vulvectomy group (P = 0.028). There was a significant
plasma KYN level decrease during measurements made prior to induction and the end of operation (bracket P < 0.001). A significant increase
occurred between points measured prior to the end of operation and 24 hours post operative (bracket P < 0.041).
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explanation for the corresponding drop in IDO activity.
Allowing for a negative feedback mechanism capable of
maintaining KYN homeostasis, KYN suppresses the acti-
vation of T cells and NK cells which are responsible for
IFN gamma secretion, one of the known factors respon-
sible for activating IDO.
Neopterin is primarily produced by human monocytes
and macrophages. Increased neopterin concentrations areindicative of cellular immune activation [19]. We found
significantly higher levels of neopterin at all five time
points in the vulvectomy group. The cancer necessitating
vulvectomy may explain these higher levels because cancer
has been correlated with higher neopterin levels [25,40]. It
is clearly evident that the time curve relationship is nearly
identical for both groups. Remarkably, anesthesia and sur-
gery did not significantly dampen or increase neopterin
levels. Instead, there seems to be a neopterin level drop
Figure 4 The effect of anesthesia in patients undergoing vulvectomy and major abdominal surgery on perioperative levels of plasma
Neopterin. Values are the mean and SEM. There was a significant within subject effect (P < 0.033) and a significant difference between
groups (P = 0.005).
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recovery to baseline level occurring during the 96 hour
time period after surgery.
Not surprisingly, patients awaiting surgery suffer high
levels of anxiety [41]. There is good evidence that in
healthy individuals, acute psychological stress causes in-
creased levels of catecholamines and cortisol, which in
turn modulate the immune system [42-45]. We specu-
late that increased stress and associated increased corti-
sol synthesis prior to surgery caused a neopterin level
decrease in the 24 hours prior to anesthesia. Opiod
based anesthesia, however, is known to suppress cortisol
synthesis and this may explain why neopterin levels do
not continue to drop after induction of anesthesia
[38,46]. Another explanation may be that the decrease in
neopterin is counteracted by an increased release of
neopterin induced by IFN γ.
Unlike our neopterin results, there are barely measur-
able IL-6 levels during the 24 hours prior to surgery. As
would be expected from an acute phase pro-inflammatory
cytokine known to be a sensitive early marker of tissue
damage, there was a sharp increase resulting in signifi-
cantly more IL-6 being made in the major abdominalsurgery group at the end of the operation compared to the
vulvectomy group. It is noteworthy that at 96 hours post
operative IL-6 levels almost return to baseline levels in
both groups. The high prevalence of mast cells in the ab-
dominal cavity might explain why an earlier and over-
whelmingly more significant amount of IL-6 is released
during the abdominal operation. A recent study provides
convincing evidence that intestinal handling during open
gynecological surgery causes mast cell activation and asso-
ciated release of IL-6 and other inflammatory mediators
[47]. When comparing with neopterin results it is reason-
able to conclude that the large IL-6 peak found in the
major abdominal surgery group is due to the more severe
surgical trauma and intestinal handling experienced by
this group.
The course of the tryptophan kynurenine pathway mea-
sured in both groups suggests that activated IDO might
buffer overzealous cellular immune system activation by
allowing for the restoration of KYN levels [38]. The trend
seen in our neopterin results supports this idea. While our
IL-6 results confirm that major abdominal surgery causes
a more acute activation of the cellular immune system
when compared to the less invasive vulvectomy group, the
Figure 5 The effect of anesthesia in patients undergoing vulvectomy and major abdominal surgery on perioperative levels of plasma
IL-6. There was a significant within subject effect (P < 0.001). The major abdominal surgery group had produced significantly more IL-6 then the
vulvectomy group 30 minutes prior to the end of the operation (P < 0.001). *Denotes significant difference at the end of operation time point,
P<0.001.
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short lived. This is confirmed by all of the data in this
study. Between the end of the operation and 24 hours after
surgery, the IL-6 peak quickly recedes to the same level
seen in the less invasive (vulvectomy) group, while a sig-
nificant kynurenine increase is seen. During this time
frame, neopterin is still depressed when compared to base-
line and 96 hour post operative levels.
In addition to its ability to suppress natural killer and T
cells, kynurenine also has a vasodilating effect that might
explain our results. It is likely that the vasodilating proper-
ties of propofol help depress kynurenine levels after induc-
tion. A recent study using animal models has found that
kynurenine plays a similarly important role in determining
arterial wall tonus as nitric oxide does [11]. The two medi-
ators act redundantly to influence vascular tone [48-50].
Although this study is primarily intended to study the
effects of differing degrees of surgery on inflammatory
markers, this study also provides data that can be inter-
preted to show that anesthesia does not seem to be strictly
immunosuppressive, but might have a buffering effect. It
seems that adequate anesthesia preserves proper immune
function while at the same time suppressing pathological
immune activation in operations like major abdominal
surgery which are more prone to a systemic inflammatory
response syndrome (SIRS). Further research is necessaryin order to investigate how opiates, hypnotic agents and
the epidural technique specifically contribute to these ef-
fects. Most evidence suggests that opiates have immuno-
modulating properties, while propofol allows for proper
function of the immune system [51-55]. It is noteworthy
that in this study there was significantly more propofol
used in the group expressing a significant IL-6 increase.
Taking this into account, it is likely that propofol is not re-
sponsible for immunosuppression.
Limitations
The significantly less amount of propofol given to the
vulvectomy group can be partly explained by the shorter
operating time. However, women in this group were
older and had higher ASA scores also explaining why
less propofol was used. In addition, the greater amount
of colloids and crystalloids given to the laparotomy
group is related to the longer operating time and in-
creased amount of blood loss in this group of patients.
Nevertheless, the results shown in our figures make it
clear that dilutional phenoma are not responsible for
trends seen. Likewise, these peri-operative characteristics
provide additional evidence that abdominal hysterec-
tomy is a heavier, more traumatic operation in compari-
son to the vulvectomy procedure. The more severe
nature of abdominal hysterectomy also explains why
Table 4 Analgesia technique applied 24 hours post
operative
Only NSAIDs NSAIDs and
intravenous
morphine
NSAIDs, intravenous
morphine and epidural
anesthesia
Vulvectomy 8 4 3
Laparotomy* 1 3 9
*Laparotomy group had significantly more invasive pain control, P < 0.05.
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gesia techniques during the 24 hour post operative
period as seen in Table 4. Generally, a heavier regimen
was chosen for heavier surgery. According to our results
this seems to have an appropriate effect because IL-6
only showed one moment where levels were different
between groups at 24 hours post operative.
Furthermore, we did not consider or note the meno-
pausal status of women when conducting this study,
however, if the menopausal status had a confounding ef-
fect it would make our results even stronger: From the
literature we know, that after menopause, there is an in-
crease in pro-inflammatory serummarkers (IL-6 and
TNF-alpha) [56]. When taking age into account, our vul-
vectomy group would have had more women who were
post-menopausal than in the abdominal hysterectomy
group. However, we found the higher IL-6-levels in the
abdominal hysterectomy, the group with the younger
patients. This supports the claim that the effect of the
procedure is stronger than changes due to aging.
One might also discuss, whether it is prudent, to use
COX-2-inhibitors as analgetics in a study on inflammation
processes. We decided to do so, because it reflects our clin-
ical standard practice and it would be considered an ethical
problem by our institutional Medica Ethics Committee to
change our pain control procedures just to create better
study conditions. There is growing evidence that the sup-
pression of inflammatory processes by COX-2-antagonists
has more than only analgetic effects: depression and the
immune response in cancer patients are two of the most
interesting fields [57-59]. We know that COX-2-inhibition
can lead to down-regulation of IDO1 and decreased kynur-
enine levels [59]. However, in our study the dosages ad-
ministered were not that extremely different and
nevertheless the group with the higher total dose of COX-
2-inhibitor had the more pronounced changes in the im-
munological profile. Despite the use of a COX-2-inhibitor
we found increased IDO-activity in both groups.
Finally, one might discuss the possible impact of the fact,
that more patients in the abdominal hysterectomy used an
epidural catheter . However, we know that an epidural cath-
eter is not able to block the stress response to major surgery
[60]. If the epidural anesthesia would have had an anti-
inflammatory effect, the differences between the groups
might have even been bigger than observed in our study.While taking all these factors into consideration, we
are aware of the fact, that our groups are not totally
similar. However, when there was a difference between
patient demographics or in the anesthetic regimen used,
they should have led to smaller differences than what
were actually observed, which must be interpreted as
extra evidence to support our theory.
Conclusion
We conclude that surgery and associated anesthesia
cause a significant decrease in tryptophan levels, while
significantly increasing IDO activity. Both types of sur-
gery produce nearly identical neopterin time curve rela-
tionships, with no significant change occurring in either
group. However, even though neopterin is unaffected by
the severity of surgery, IL-6 responded to surgical inva-
siveness by revealing a significant increase during major
abdominal surgery.
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